Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-005294
Filing Date
2012-02-02
Accepted
2012-02-02 16:33:46
Documents
1
Period of Report
2012-02-01

Document Format Files

Seq Description Document Type Size
1 SOLOWAY ANNUAL GRANT rrd332254.html 4  
1 SOLOWAY ANNUAL GRANT rrd332254.xml 4 3787
  Complete submission text file 0001181431-12-005294.txt   5315
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCEPT PHARMACEUTICALS INC 1003 W CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address
Soloway Thomas P (Reporting) CIK: 0001454280 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 12566316